"Fibrinolytic" Natural Recordings by Native Speakers
Fibrinolytic refers to a substance or process that breaks down fibrin, a blood protein that forms clots. Fibrinolytic agents are used to dissolve blood clots and restore blood flow in the body. They are often used in medical treatments for conditions such as acute myocardial infarction, deep vein thrombosis, and pulmonary embolism.
Fibrin is a protein that is produced by the liver and plays a crucial role in blood clotting. It is an insoluble fibrous protein that forms a mesh-like structure, trapping platelets and red blood cells to create a blood clot. This helps to stop bleeding after an injury or surgical procedure. Fibrin is derived from fibrinogen, a soluble protein found in blood plasma, which is converted to fibrin during the blood clotting process.
Fibrination refers to the process by which a liquid protein, such as fibrinogen, is converted into a solid fibrin thread or clot, often as a result of blood clotting.
Fibrin is a type of protein that forms a blood clot by combining with other blood components, helping to stop bleeding.
Fibrinogenous refers to something that is capable of producing or forming fibrin, a type of protein that plays a crucial role in blood clotting.
Fibrinoid refers to a type of amorphous, granular, or proteinaceous substance that forms in tissues and organs, often as a result of inflammation or disease. It is typically composed of a mixture of fibrin, a protein produced by blood platelets, and other substances such as collagen, elastin, and mucopolysaccharides. Fibrinoid material can deposited in the walls of blood vessels, in skin, in connective tissue, and in other parts of the body. It is often seen in conditions such as rheumatic fever, lupus, and vasculitis.
Fibrinolysin is an enzyme that breaks down fibrin, a protein that forms blood clots. It is an important component of the body's natural process of blood clotting resolution, helping to dissolve and remove blood clots after they are no longer needed. Fibrinolysin is often used as a therapeutic agent to treat conditions such as deep vein thrombosis and pulmonary embolism.
Fibrinolysis is the process by which the blood breaks down and dissolves blood clots. It is an important part of the body's natural response to injury or inflammation, as it helps prevent excessive clotting and ensures that blood flow is restored to affected areas. Fibrinolysis is mediated by enzymes such as plasminogen activators, which convert plasminogen to plasmin, a protease that degrades fibrin, the main component of blood clots.
Fibrinoplastin is an obsolete term that refers to a protein that was previously believed to play a role in blood clotting. However, it is now known that fibrin is the main protein involved in blood clotting, and fibrinoplastin is no longer considered a valid or useful term in medical or biological contexts.
Fibrinous refers to something that is relating to or consisting of fine thread-like fibers or filaments, typically in a shapeless or irregular mass. In medical contexts, fibrinous often refers to a type of tissue that forms as a result of inflammation or blood clotting, characterized by the presence of a loose network of fibers or strands.
Fibroadenomas are benign breast tumors that are typically non-cancerous and do not spread to other parts of the body. They are the most common type of non-cancerous breast tumor, accounting for about 70% of all benign breast tumors. Fibroadenomas are usually small, firm, and mobile, and can appear in both men and women. They are often diagnosed incidentally, during a routine breast exam or mammogram. While they are generally harmless, fibroadenomas can cause some discomfort, and in rare cases, they may need to be removed surgically if they become painful or interfere with breastfeeding.
Fibroadenomata are benign tumors that typically occur in the breast tissue of young women. They are also known as breast hamartomas or fibroadenomas. They are usually round, firm, and mobile, and are often found in the upper outer quadrant of the breast. Fibroadenomata are non-cancerous and do not usually cause any symptoms, but can sometimes cause discomfort or abnormal milk production. They are usually treated with removal, but most do not require treatment if they are small and benign.